Abstract | OBJECTIVES: METHODS AND RESULTS: CONCLUSIONS: These results suggest that excessive activation of the alternative complement pathway is associated with ADPKD progression, probably mediated by cyst-lining epithelial cell proliferation, tubulointerstitial inflammatory cell infiltration and fibrosis. Targeting the complement system might represent a new therapeutic strategy for ADPKD.
|
Authors | Z Su, X Wang, X Gao, Y Liu, C Pan, H Hu, R P Beyer, M Shi, J Zhou, J Zhang, A L Serra, R P Wüthrich, C Mei |
Journal | Journal of internal medicine
(J Intern Med)
Vol. 276
Issue 5
Pg. 470-85
(Nov 2014)
ISSN: 1365-2796 [Electronic] England |
PMID | 24494798
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Copyright | © 2014 The Association for the Publication of the Journal of Internal Medicine. |
Chemical References |
- Complement C3
- Complement C4
- Complement C9
- Complement System Proteins
- Complement Factor B
|
Topics |
- Adult
- Animals
- Cell Proliferation
- Complement C3
(metabolism)
- Complement C4
(metabolism)
- Complement C9
(metabolism)
- Complement Factor B
(metabolism)
- Complement Pathway, Alternative
(drug effects)
- Complement System Proteins
(urine)
- Disease Progression
- Epithelial Cells
(metabolism)
- Fibrosis
- Humans
- Kidney
(metabolism, pathology)
- Mice, Knockout
- Middle Aged
- Polycystic Kidney, Autosomal Dominant
(immunology, pathology, urine)
- Rats
|